The pWSK29 plasmid with the 5-kb insert was isolated using the Qiagen Spin Miniprep kit, and the insert was confirmed by DNA sequencing. Next, each of the F. novicida flmF homologues, with their flanking inserts in pWSK29, were replaced with a kanamycin resistance gene. Tn903 from plasmid pWKS130 (4) was amplified by PCR using primers Kan+ and Kan-(Supporting Table 1 ). It was flanked on its 5′ and 3′ ends by 50 bp of the chromosomal DNA that is immediately upstream or downstream of F. novicida flmF1 and flmF2. The PCR was performed using Pfu Turbo polymerase.
Amplification was carried out in a 50-µL reaction mixture containing 50 ng of template, 100 ng of primers, and 1 unit of Pfu Turbo polymerase. The reaction was started at 94 °C for 1 min, followed by 25 cycles of denaturation (45 s at 94 °C), annealing (45 s at 55 °C), and extension (60 s at 72 °C). The PCR product was purified and electroporated into E. coli DY330/pWSK29, containing either the flmF1 or flmF2 gene in the 5-kb insert described above, which had been grown at 30 °C until A 600 reached 0.5 and then induced at 42 °C for 20 min. After electroporation, recombination occurred between the homologous sequences of the linear PCR product and the flmF1 or flmF2 gene on the pWSK29 hybrid plasmid at 30 °C, resulting in replacement of each flmF homologue with the kanamycin resistance gene. The desired plasmids were then isolated from kanamycin-resistant transformants, selected on LB agar containing 20 µg/mL kanamycin and 100 µg/mL ampicillin, and digested with XhoI and SacII. About 100 ng of each linear DNA containing the kan insert was gel-purified, and the replacement of F. novicida flmF1 and flmF2 with the kanamycin resistance gene on these plasmids was verified by DNA sequencing.
In order to replace each flmF homologue present in the genome of F. novicida with the kanamycin resistance gene, F. novicida U112 cells were grown in 100 mL of Chamberlain's medium (7) to A 600 of 0.5. The cells were harvested by centrifugation and resuspended in 5 mL of transformation buffer (8) . A volume of 1 mL of the cell suspension was mixed with 100 ng of the linear DNA, prepared as described above, and shaken at 100 rpm at 37 °C for 30 min. Next, 5 mL of Chamberlain's medium was added, and the mixture was shaken at 37 °C for 2 h at 250 rpm. The cells were harvested and resuspended in 1 mL of TSB-C medium (3% trypticase soy broth and 0.1% cysteine).
Approximately 100 µL of the cell suspension was spread onto a TSB-C plate containing 10 µg/mL kanamycin. Genomic DNA was isolated from a kanamycin-resistant transformant, and the replacement of each F. novicida flmF gene with the kanamycin Table 1 ) were designed with a clamp region, an XhoI restriction site, and a homologous region to the anti-coding strand of chromosomal DNA of the F. novicida genes. The PCR was performed using Pfu Turbo polymerase and F. novicida genomic DNA as the template. Amplification was carried out in a 50-µL reaction mixture containing 100 ng of template, 100 ng of primers, and 1 unit of polymerase. The reaction was started at 94 °C for 2 min, followed by 25 cycles of denaturation (45 s at 94 °C), annealing (45 s at 50 °C), and extension (2 min at 72 °C). After the 25th cycle, a 10 min extension time was used. The reaction product was analyzed on a 1% agarose gel, and the desired band was excised and gel-purified. The PCR product was then digested using XhoI and NcoI and ligated into the expression vector pET28b, which had been similarly digested and treated with Antarctic phosphatase (New England Biolabs, Ipswich, MA).
The ligation mixture was transformed into XL1-Blue cells, and the kanamycin-resistant colonies were selected on LB plates with 20 µg/mL kanamycin. The plasmids pET28b-flmF1 or pET28b-flmF2 were isolated and transformed into E. coli NovaBlue (DE3) cells after the DNA sequence was confirmed. . 1A) , the DEAE cellulose elution behavior (not shown), and the ESI/MS analysis (Supporting Fig. 1B -1D ) strongly support the proposed structures (Fig. 1 of the manuscript) .
Preparation of Total Lipids and Purification of Free Lipid

Enzymatic synthesis of Undecaprenyl Phosphate-Glucose and Undecaprenyl
Phosphate-GalNAc. The reaction mixture for the synthesis of undecaprenyl phosphateglucose or undecaprenyl phosphate-GalNAc contained 0.02 mg/mL membranes from E.
coli NovaBlue(DE3) cells expressing FlmF1 or FlmF2, 100 µM sugar nucleotides (UDPglucose or UDP-GalNAc), 50 µM undecaprenyl phosphate, 0.2% Triton X-100, and 50 mM HEPES, pH 7.5. After 24 h at30 °C, the mixture was converted to a two-phase Bligh-Dyer system and centrifuged; the lower phase was collected and dried down by flmF1 and flmF2 genes.
Primer Name Primer Sequences TLC, LC-ESI/MS and LC-ESI/MS/MS in the negative ion mode of undecaprenyl phosphate-glucose and undecaprenyl phosphate-GalNAc. Undecaprenyl phosphateglucose and undecaprenyl phosphate-GalNAc were synthesized in 1 mL reaction mixtures containing 0.02mg/mL of recombinant FlmF1 or FlmF2 membranes, with either 100 µM UDP-glucose or 100 µM UDP-GalNAc respectively, 25 µM undecaprenyl phosphate, 0.1% Triton X-100 and 50 mM Hepes (pH7.5). The mixture was incubated at 30 °C for 24 hours. The purification of the two products is described in the Supporting Materials and Methods section. Panel A. The TLC plate was developed using the solvent chloroform/methanol/water/ammonium hydroxide (65:25:3.6:0.4, v/v/v/v), and the purified compounds were detected by spraying the plate with 10% sulfuric acids in ethanol, followed by charring. 
